Doximity Inc (DOCS)

Currency in USD
20.26
+0.74(+3.79%)
Closed·
20.29+0.03(+0.15%)
·
DOCS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
19.5220.50
52 wk Range
17.1576.51
Key Statistics
Prev. Close
19.52
Open
19.54
Day's Range
19.52-20.5
52 wk Range
17.15-76.51
Volume
3.49M
Average Volume (3m)
3.75M
1-Year Change
-61.1132%
Book Value / Share
5.15
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
DOCS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
25.15
Upside
+24.14%
Members' Sentiments
Bearish
Bullish
ProTips
Holds more cash than debt on its balance sheet

Doximity Inc News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Technical Indicators
Strong Buy
Moving Averages
Neutral

Analyst Ratings

10 Buy
12 Hold
0 Sell
Ratings:
22 analysts
Overall Consensus
Buy

Analysts 12-Month Price Target:

Average 25.15
(+24.14% Upside)
Firm
ArticlePositionPrice TargetUpside / DownsideFrom Price TargetActionDate
BofA Securities
Buy38.00+87.56%47.00MaintainMay 15, 2026
Barclays
Hold20.00-1.28%38.00DowngradeMay 14, 2026
Morgan Stanley
Buy35.00+72.75%49.00MaintainMay 14, 2026
JPMorgan
Hold28.00+38.20%33.00MaintainMay 14, 2026
BMO Capital
Hold20.00-1.28%25.00MaintainMay 14, 2026

Doximity Inc SWOT Analysis


Digital Health Giant
Doximity dominates the healthcare professional network space, connecting over 80% of U.S. physicians and offering marketing, hiring, and telehealth solutions.
Financial Crossroads
Despite impressive margins and growth, Doximity faces valuation scrutiny. Analysts project revenue of $619-631 million for FY2026, with an average price target of $67.40.
Innovation Frontie
Explore Doximity's strategic acquisitions and AI investments, potentially driving long-term growth and efficiency in the evolving digital health landscape.
Market Dynamics
Delve into how shifting pharma advertising trends and potential healthcare reforms could reshape Doximity's revenue streams and competitive positioning.
Read full SWOT analysis

Doximity Inc Earnings Call Summary for Q4/2026

  • Doximity Q4 2026 EPS of $0.26 missed forecast of $0.28 by 7.14%; revenue beat expectations at $145.4M vs. $144.07M, up 5% YoY.
  • Stock plunged 11.57% to $26.36 in aftermarket trading as increased AI compute costs compressed margins despite strong 90% gross profit margin.
  • Free cash flow rose 11% YoY to $107M; adjusted EBITDA reached $66M with 45% margin, demonstrating solid operational performance.
  • Management emphasized strategic AI investments as critical for competitive edge, though near-term margin pressure expected to continue.
  • Key risks include ongoing AI infrastructure costs, digital pharma market volatility, and macroeconomic uncertainties affecting customer spending.
Last Updated: 2026-05-13, 06:16 p/m
Read Full Transcript

Earnings

Latest Release
May 13, 2026
EPS / Forecast
0.26 / 0.28
Revenue / Forecast
145.4M / 144.07M
EPS Revisions
Last 90 days

DOCS Income Statement

Compare DOCS to Peers and Sector

Metrics to compare
DOCS
Peers
Sector
Relationship
P/E Ratio
18.2x13.3x−0.5x
PEG Ratio
−1.610.030.00
Price/Book
3.8x0.8x2.6x
Price / LTM Sales
5.5x1.2x3.1x
Upside (Analyst Target)
18.5%34.6%53.2%
Fair Value Upside
Unlock38.6%6.2%Unlock

Doximity, Inc. operates a digital platform for medical professionals in the United States. Its Doximity platform includes a personalized newsfeed that presents clinical and professional content to members, which offers medical articles, clinical trials or research results in an easy-to-consume video format, professional updates and accomplishments of their peers and colleagues, clinical discussions, Op-Med articles for publication, and sponsored content from pharmaceutical manufacturers and health systems. The company also offers workflow tools, including Ask, a HIPAA-compliant AI assistant, to access and apply evidence-based medical information within clinical workflows; Scribe, a HIPAA-compliant, AI-powered clinical documentation tool; Telehealth tools for hospitals and health systems; and AMiON, an on-call scheduling tool. The company primarily serves physicians, nurse practitioners, physician assistants, medical students, pharmaceutical manufacturers, and healthcare systems. The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010. Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.

Employees
880

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
59.77M32.36%1.17B
Other Institutional Investors
70.28M38.05%1.37B
Public Companies & Retail Investors
54.67M29.60%1.07B
Total
184.71M100.00%3.61B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
BlackRock, Inc.7.70%14,217,297277,522
The Vanguard Group, Inc.7.19%13,285,485259,333

People Also Watch

32.22
TDC
-3.36%
53.16
CTSH
+2.61%
32.85
CPRT
-1.17%
55.62
FISV
+0.02%
199.84
CAH
-0.26%

FAQ

What Is the Doximity (DOCS) Stock Price Today?

The Doximity stock price today is 20.26 USD.

What Stock Exchange Does Doximity Trade On?

Doximity is listed and trades on the New York Stock Exchange.

What Is the Stock Symbol for Doximity?

The stock symbol for Doximity is "DOCS."

What Is the Doximity Market Cap?

As of today, Doximity market cap is 3.72B USD.

What Is Doximity's Earnings Per Share (TTM)?

The Doximity EPS (TTM) is 0.98.

When Is the Next Doximity Earnings Date?

Doximity will release its next earnings report on Aug 11, 2026.

From a Technical Analysis Perspective, Is DOCS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.

How Many Times Has Doximity Stock Split?

Doximity has split 0 times.

How Many Employees Does Doximity Have?

Doximity has 880 employees.

What is the current trading status of Doximity (DOCS)?

As of May 27, 2026, Doximity (DOCS) is trading at a price of 20.26 USD, with a previous close of 19.52 USD. The stock has fluctuated within a day range of 19.52 USD to 20.50 USD, while its 52-week range spans from 17.15 USD to 76.51 USD.

What Is Doximity (DOCS) Price Target According to Analysts?

The average 12-month price target for Doximity is 25.15 USD, with a high estimate of 42 USD and a low estimate of 18 USD. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +24.14% Upside potential.

What Is the DOCS Premarket Price?

DOCS's last pre-market stock price is 19.50 USD. The pre-market share volume is 21,370.00, and the stock has decreased by -0.02, or -0.10%.

What Is the DOCS After Hours Price?

DOCS's last after hours stock price is 20.29 USD, the stock has decreased by 0.03, or 0.15%.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.